Endo Axiom
PrivateLast Round
Grant
Jun 30, 2025
Total Funding Raised
$2.22M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Endo Axiom is a biotechnology company developing platforms for the oral delivery of drugs and biologics, including an oral smart insulin and an immune modulation platform to prevent type one diabetes.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Medical Imaging, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endo Axiom Comparables
Compare Endo Axiom with similar companies based on industry and business-model similarity.
Endo Axiom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 30, 2025 | ||||
| Seed | Apr 18, 2023 |
Endo Axiom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Proto Axiom | Seed |
| MTPConnect | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 106% MoM, reaching 2.4K.
- May 16, 2026
Monthly visitors increased 151% MoM, reaching 1.2K.
Endo Axiom Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endo Axiom's valuation, stock price, and market status.